Latest filing published 09 Jan 2026 for SELLAS Life Sciences Group, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of John Varian across 3 companies, led by XOMA Royalty Corp, Aravive, Inc. and SELLAS Life Sciences Group, Inc. The record holds 92 filings, for trades running from 13 November 2012 to 7 January 2026.
Sales make up the whole of the open-market record (39 sales, €2.1M). No amount is published for 2 filings, which the totals therefore leave out. Other entries cover 12 share grants and 38 option exercises.
The record was last updated on 9 January 2026 with a share grant in SELLAS Life Sciences Group, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations